ReviewFrontiers in psychiatry2026
The microbiota-gut-brain axis in postpartum depression: a review of microbial mechanisms and therapeutic potential.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postpartum depression (PPD), a common but mechanistically uncertain mood disorder, occurs in 10-15% of mothers and seriously affects maternal and infant health. Recent evidence suggests that alteration of gut microbiota could dysregulate gut-brain axis functioning, which is potentially linked to the pathogenesis of PPD. This review innovatively synthesizes up-to-date preclinical and clinical evidence to illustrate relevant mechanisms, including microbial metabolite signaling, immune-inflammatory pathways, and neuroendocrine disruptors. Furthermore, the therapeutic potential of microbial-targeting approaches, including probiotics, dietary changes, and fecal microbiota transplant, to remedy PPD by restoring microbial health is discussed. Nevertheless, several notable limitations, translational uncertainties and major knowledge gaps still exist in this field. Most current evidence derives from cross-sectional observations, and well-designed longitudinal human studies are urgently needed to confirm causal relationships. In addition, available microbiota-related interventions have not yet developed into mature precision microbiome therapeutics. Against this background, this study proposes a microbiome framework connecting basic science and clinical applications that may help unravel the etiology and treatment of PPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.